Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Liabilities and Shareholders Equity (2020 - 2025)

Beauty Health (SKIN) has disclosed Liabilities and Shareholders Equity for 6 consecutive years, with $503.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 28.01% to $503.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.4 billion, a 25.57% decrease, with the full-year FY2024 number at $685.7 million, down 26.2% from a year prior.
  • Liabilities and Shareholders Equity was $503.6 million for Q3 2025 at Beauty Health, down from $507.6 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.2 billion in Q4 2021 to a low of $342.5 million in Q2 2021.
  • A 5-year average of $827.9 million and a median of $844.7 million in 2024 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 227928.9% in 2021, then dropped 28.7% in 2025.
  • Beauty Health's Liabilities and Shareholders Equity stood at $1.2 billion in 2021, then decreased by 17.7% to $1.0 billion in 2022, then fell by 7.37% to $929.1 million in 2023, then fell by 26.2% to $685.7 million in 2024, then fell by 26.55% to $503.6 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Liabilities and Shareholders Equity are $503.6 million (Q3 2025), $507.6 million (Q2 2025), and $673.8 million (Q1 2025).